Prognostic Value of BIRC5 in Lung Adenocarcinoma Lacking EGFR, KRAS, and ALK Mutations by Integrated Bioinformatics Analysis

Lignende værker

• Fusion of EML4 and ALK is associated with development of lung adenocarcinomas lacking EGFR and KRAS mutations and is correlated with ALK expression
  af: Zhang, Xuchao, et al.
  Udgivet: (2010)
• Analysis of the frequency of EGFR, KRAS and ALK mutations in patients with lung adenocarcinoma in Croatia
  af: Brcic, Luka, et al.
  Udgivet: (2016)
• Identification of somatic mutations in EGFR/KRAS/ALK-negative lung adenocarcinoma in never-smokers
  af: Ahn, Jin Woo, et al.
  Udgivet: (2014)
• Value of CT features for predicting EGFR mutations and ALK positivity in patients with lung adenocarcinoma
  af: Han, Xiaoyu, et al.
  Udgivet: (2021)
• The Prognostic and Predictive Value of KRAS Oncogene Substitutions in Lung Adenocarcinoma
  af: Villaruz, Liza C., et al.
  Udgivet: (2013)